Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2014, Vol. 19 ›› Issue (4): 381-384.
Previous Articles Next Articles
LI Qin1, LI Xiao-li2, ZHAO Yin1, ZHANG Ping-qing2, ZHANG Xin-yue1
Received:
2013-08-24
Revised:
2014-03-14
Online:
2014-04-26
Published:
2020-07-24
CLC Number:
LI Qin, LI Xiao-li, ZHAO Yin, ZHANG Ping-qing, ZHANG Xin-yue. Studies on the changes of chronic pelvic inflammatory disease(CPID) rat model of Penyankunhe liquor[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(4): 381-384.
[1] 陈林海.康妇消炎栓联合抗生素治疗盆腔炎性疾病80例疗效分析[J].中国临床药理学与治疗学,2011,16(4):435-438. [2] 孙晓玮,程体娟,罗慧英,等.竹叶椒片对大肠杆菌所致大鼠慢性盆腔炎的治疗作用[J].中国临床药理学与治疗学,2005,10(7):804-807. [3] 徐文峥,江伟华.红藤汤中药配方颗粒治疗慢性盆腔炎的临床观察[J].中国中药杂志,2011,36(10):1386-1387. [4] Cao D.Clinical application of the empirical prescriptions for chronic pelvic inflammation[J].J Tradit Chin Med,2004,24(2):112-115. [5] 陈奇,林志彬,张建宁,等.中药药效研究思路与方法[M].北京:人民卫生出版社,2005:854-859. [6] 向绍杰,孟莉,乔敏,等.盆炎净颗粒对苯酚胶浆所致大鼠慢性盆腔炎动物模型的影响[J].辽宁中医药大学学报,2009,11(8):241-242. [7] 贾丽娜,赵世萍,闫静,等.妇科千金软胶囊治疗盆腔炎药效学研究[J].中药新药与临床药理,2006,17(1):18-20. [8] 张樱山,李文雅,赵晖,等.红花如意丸治疗大鼠慢性盆腔炎的研究[J].中国实验方剂学杂志,2011,17(8):180-184. [9] 谷风.利湿化瘀法对慢性盆腔炎大鼠血清SOD、MDA影响的实验研究[J].陕西中医,2010,31(4):496-497. [10] 刘国生,王桐生,龙子江,等.盆腔炎冲剂对大鼠慢性盆腔炎模型的影响[J].中国实验方剂学,2004,10(3):24-26. |
[1] | CAO Xuefen, LENG Yufang, HAN Xiaoxia, HOU Xiaoyu, LYU Xingjiao, Janvier NIBARUTA. Tetramethylpyrazine protected against intestinal ischemia-reperfusion injury induced pyroptosis by inhibiting NLRP3 inflammasome activation [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(11): 1201-1208. |
[2] | WANG Jian, SUN Yongdong, ZHOU Xingwei, LIU Lei, CHEN Long, TONG Xingke, ZHU Jiali. Baicalein promotes laryngeal cancer cell death and inhibits invasion via miR-125b-5p/IRF4 axis [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(11): 1209-1218. |
[3] | ZHU Ruifang, GUO Dongkai, ZHI Hui, JIANG Yiguo, ZHANG Yueling, QIAN Xiaoping, JI Shiliang. Exploring the mechanism of elemene synergistic bortezomib against multiple myeloma by ROS-NF-κB-p38MAPK pathway [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(11): 1219-1226. |
[4] | LI Fei, DING Huiqin, CHEN Mengjing. Isonlosinine induces autophagy of PC9 cells by ERK signaling pathway in lung cancer [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(11): 1235-1240. |
[5] | SHI Dandan, SUN Yiyao, CHEN Xiaoqi, YANG Fangming, ZHANG Chuanlei, WANG Xinting, YUAN Changwei, CHEN Xinju. Curative effect of fuzheng xiaoliu granules in the treatment of primary liver cancer and analysis of serum metabolomics [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(11): 1247-1262. |
[6] | CHEN Yulin, JIANG Hugang, WANG Xinqiang, LIU Kai, LI Yingdong, AN Tao, ZHAO Xinke. Effects and mechanism of Ginseng Yixin granules (QSYXG) for heart failure with preserved ejection fraction based on the network pharmacology and molecular docking strategy [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(10): 1081-1092. |
[7] | WANG Xiu, JI Qilin, PEI Wenjun, ZENG Ying. 3-bromopyruvate cholesterol ester enhances the sensitivity of breast cancer cells to tamoxifen [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(10): 1093-1100. |
[8] | HENG Bingbing, YANG Danfeng, DAI Shuyang, SHANGGUAN Wangning. Propofol relieves the subcutaneous chloroquine-induced pruritus in rats via TRPV1 and CB1 receptors of spinal cord [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(10): 1101-1108. |
[9] | LIAO Mengling, WANG Yan, LUO Jing, WANG Nuoyan, HUA Ling, ZHANG Yu, DENG Fei, YUAN Yue, ZHOU Jun, ZHOU Hong. Molecular mechanism of artesunate attenuates the release of proinflammatory cytokines from macrophages [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(9): 969-978. |
[10] | YOU Rongli, HUANG Yurong, MAORui, HAI Lina, WANG Yingli, WANG Yan. Mechanism of compound kushen injection in the treatment of lung cancer based on serum metabolomics and network pharmacology [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(9): 988-999. |
[11] | WANG Ruyue, XIE Fei, WANG Xin, LI Hongyu. Therapeutic effect of lienal polypeptide injection on bone marrow suppression and immunodeficiency in KM mice following chemotherapy [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(9): 1000-1007. |
[12] | MAO Jun, RONG Yu, LI Yangen, XIONG Dengxi, ZHAO Peng, ZHA Zhengjiang. Effect and safety of flurbiprofen axetil in the analgesic treatment of patients with craniocerebral injury [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(9): 1056-1060. |
[13] | MA Xiankang, YANG Lixia, CUI Yangyang, MI Denghai. Angelica polysaccharides improve hepatic endoplasmic reticulum stress by inhibiting the expression of GRP78, p-PERK and p-Eif2α in diabetic KK-Ay mice [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(8): 926-936. |
[14] | WANG Kun, XU Peipei, ZHOU Lanlan, LU Sheng. Mechanism of neuroprotective effect of ginsenoside Rg1 regulating Epac1/Rap1 signaling pathway in rats with ischemic stroke [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(7): 721-727. |
[15] | LI Shixu, LI Linyun, WANG Xin, LI Ke, BIAN Hua. Effects of Ginkgo biloba extract on renal injury in rats with experimental renal failure through miR-145/FOXO1 axis [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(7): 728-735. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||